Officer Chew Files To Sell 19,993 Of Accuray Inc [ARAY]

Officer Chew Jesse of Accuray Inc filed a Form 144 with the SEC to sell 19,993 shares on December 2, 2025, under a prearranged trading plan (10b5-1). The sale is executed through E-TRADE Financial. Form 144 is required for selling restricted stock, allowing the sale within 90 days of filing. The Washington Service provides related insider trading analysis and data services.

Accuray CEO Stephen R. La Neve Reports Acquisition of Common Shares

Stephen R. La Neve, CEO and Director of Accuray Incorporated, reported the acquisition of common shares of the company. The full filing is available via EDGAR, the U.S. SEC's system.

Accuray Incorporated Held Annual Shareholder Meeting

Accuray Incorporated held its Annual Meeting of Stockholders on November 13, 2025, where stockholders elected new board members, approved the 2026 Equity Incentive Plan, and ratified Grant Thornton LLP as the accounting firm for fiscal year 2026.

Accuray’s Earnings Call: Mixed Sentiments and Future Prospects

Accuray Incorporated's Q1 earnings call revealed mixed sentiments, highlighting growth in service revenue but challenges with declining net revenue and increased operating losses. The company launched the Stellar product and signed a memorandum with the University of Wisconsin to advance adaptive radiotherapy. Despite a 7% decline in net revenue to $94 million and a 23% drop in product revenue, Accuray maintained its fiscal year guidance, projecting revenues of $471-$485 million. The order backlog stands at $396 million, indicating potential for improved performance in the second half of the fiscal year.

Accuray shares are trading lower after the company reported a Q1 EPS miss. Also, BTIG lowered the price target on the stock from $5 to $4.